Correlation Between Medicus Pharma and Berkshire Hathaway
Can any of the company-specific risk be diversified away by investing in both Medicus Pharma and Berkshire Hathaway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicus Pharma and Berkshire Hathaway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicus Pharma and Berkshire Hathaway CDR, you can compare the effects of market volatilities on Medicus Pharma and Berkshire Hathaway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicus Pharma with a short position of Berkshire Hathaway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicus Pharma and Berkshire Hathaway.
Diversification Opportunities for Medicus Pharma and Berkshire Hathaway
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Medicus and Berkshire is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Medicus Pharma and Berkshire Hathaway CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkshire Hathaway CDR and Medicus Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicus Pharma are associated (or correlated) with Berkshire Hathaway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkshire Hathaway CDR has no effect on the direction of Medicus Pharma i.e., Medicus Pharma and Berkshire Hathaway go up and down completely randomly.
Pair Corralation between Medicus Pharma and Berkshire Hathaway
Assuming the 90 days trading horizon Medicus Pharma is expected to generate 10.56 times more return on investment than Berkshire Hathaway. However, Medicus Pharma is 10.56 times more volatile than Berkshire Hathaway CDR. It trades about 0.21 of its potential returns per unit of risk. Berkshire Hathaway CDR is currently generating about -0.16 per unit of risk. If you would invest 290.00 in Medicus Pharma on September 16, 2024 and sell it today you would earn a total of 105.00 from holding Medicus Pharma or generate 36.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Medicus Pharma vs. Berkshire Hathaway CDR
Performance |
| Timeline |
| Medicus Pharma |
| Berkshire Hathaway CDR |
Medicus Pharma and Berkshire Hathaway Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medicus Pharma and Berkshire Hathaway
The main advantage of trading using opposite Medicus Pharma and Berkshire Hathaway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicus Pharma position performs unexpectedly, Berkshire Hathaway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkshire Hathaway will offset losses from the drop in Berkshire Hathaway's long position.| Medicus Pharma vs. Apple Inc CDR | Medicus Pharma vs. NVIDIA CDR | Medicus Pharma vs. Microsoft Corp CDR | Medicus Pharma vs. Amazon CDR |
| Berkshire Hathaway vs. Canadian Imperial Bank | Berkshire Hathaway vs. Fairfax Financial Holdings | Berkshire Hathaway vs. iA Financial | Berkshire Hathaway vs. VersaBank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |